Thermo Fisher Scientific takes over Doe & Ingalls Management
Doe & Ingalls will become part of the customer channels division of Thermo Fisher’s laboratory products and services business. Doe & Ingalls, based in Durham, North Carolina, manufactures
The US Food and Drug Administration (FDA) is set to review Kowa Pharmaceuticals America’s new drug application (NDA) for K-911, an investigational once-daily eye drop aimed at reducing intraocular pressure (IOP) in open-angle glaucoma (OAG) or ocular hypertension (OHT) patients.